Differences in yeast intolerance between patients with Crohn's disease and ulcerative colitis

Diseases of the Colon and Rectum

Volumn 50, Issue 1, 2007, Pages 83-88

  Brunner, Brigitt ^a,b   Scheurer, Ulrich ^a   Seibold, Frank ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Kantonsspital Uri   (Switzerland)

Author keywords

Antibodies against the yeast Saccharomyces cerevisiae; Crohn's disease; Ulcerative colitis; Yeast intolerance

Indexed keywords

ARTICLE; CONTROLLED STUDY; COURSE EVALUATION; CROHN DISEASE; EATING HABIT; ENVIRONMENTAL FACTOR; FEMALE; FOOD INTAKE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; NUTRIENT CONTENT; NUTRITIONAL ASSESSMENT; NUTRITIONAL INTOLERANCE; OUTPATIENT DEPARTMENT; PATIENT INFORMATION; QUESTIONNAIRE; SAMPLE SIZE; ULCERATIVE COLITIS; YEAST;

EID: 33846411815     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/s10350-006-0749-1     Document Type: Article

References (23)

1. BM Calkins 1989 A meta-analysis of the role of smoking in inflammatory bowel disease Dig Dis Sci 34 1841 1854
2. LR Sutherland S Ramcharan H Bryant G Fick 1990 Effect of cigarette smoking on recurrence of Crohn's disease Gastroenterology 98 1123 1128
3. CL Sutton H Yang Z Li JI Rotter SR Targan J Braun 2000 Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease Gut 46 58 63
4. S Vermeire S Joossens M Peeters 2001 Comparative study of ASCA (anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease Gastroenterology 120 827 833
5. F Seibold O Stich R Hufnagl S Kamil M Scheurlen 2001 Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a family study Scand J Gastroenterol 36 196 201
6. S Vermeire M Peeters R Vlictinck 2001 Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families Inflamm Bowel Dis 7 8 15
7. M Peeters S Joossens S Vermeire R Vlietinck X Bossuyt P Rutgeerts 2001 Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease Am J Gastroenterol 96 730 734
8. V Annese A Andreoli A Andriulli 2001 Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease and ulcerative colitis: aGISC study Am J Gastroenterol 96 2407 2412
9. JF Quinton B Sendid D Reumaux 1998 Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role Gut 42 788 791
10. A Konrad C Rutten B Flogerzi M Styner B Goke F Seibold 2004 Immune sensitization to yeast antigens in ASCA-positive patients with Crohn's disease Inflamm Bowel Dis 10 97 105
11. F Seibold A Konrad B Flogerzi 2004 Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease Gastroenterology 127 1076 1084
12. R Medzhitov 2001 Toll-like receptors and innate immunity Nat Rev Immunol 1 135 145
13. H Tada E Nemoto H Shimauchi 2002 Saccharomyces cerevisiae and Candida albicans derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD 14- and Toll-like receptor 4- dependent manner Microbiol Immunol 46 503 512
14. D Franchimont S Vermeire H Housni 2004 Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis Gut 53 987 992
15. A Mitchell G Guyatt J Singer 1988 Quality of life in patients with inflammatory bowel disease J Clin Gastroenterol 10 306 310
16. G Guyatt A Mitchell EJ Irvine 1989 A new measure of health status for clinical trials in inflammatory bowel disease Gastroenterology 96 804 810
17. J Kocourek CE Ballou 1969 Method for fingerprinting yeast cell wall mannans J Bacteriol 100 1175 1181
18. JF Mayberry J Rhodes 1984 Epidemiological aspects of Crohn's disease: a review of literature Gut 25 886 899
19. BM Calkins AI Medeloff 1986 Epidemiology of inflammatory bowel disease Epidemiol Rev 8 60 91
20. GR Barclay H [tmp] McKenzie J Pennington D Parratt CR Pennington 1992 The effect of dietary yeast on the activity of stable chronic Crohn's disease Scand J Gastroenterol 27 196 200
21. EA Vasiliauskas LY Kam LC Karp J Gaiennie H Yang SR Targan 2000 Marker antibody expression stratifies Crohn's disease into immunologically homogenous subgroups with distinct clinical characteristics Gut 47 487 496
22. LJ Walker MC Aldhous HE Drummond 2004 Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations Clin Exp Immunol 135 490 496
23. A Zholudev D Zurakowski W Young A Leichtner A Bousvaros 2004 Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype Am J Gastroenterol 99 2235 2241